ViewRay Incorporated
RELATED CONTENT
ViewRay Inc. announced today that patient treatments are scheduled to begin in Boston with ViewRay's MRIdian Linac System at Dana-Farber/Brigham and Women's Cancer Center. The MRIdian provides for the delivery of radiation therapy to targeted tumors while simultaneously providing continuous magnetic resonance imaging (MRI).
October 08, 2019 
ViewRay Inc. announced that the company's MRIdian and MRIdian Linac magnetic resonance imaging (MRI)-guided radiation therapy systems will be featured at the 2019 annual meeting of the American Society for Radiation Oncology (ASTRO), Sept. 15-19 in Chicago. The meeting will feature a number of presentations highlighting the capabilities, clinical experience and patient outcomes with ViewRay's MRIdian and MRIdian Linac.
September 11, 2019 
August 19, 2019 — ViewRay Inc. announced the acceptance of publication by the International Journal of Radiation ...
August 19, 2019 Leigh Conroy, Ph.D., physics resident, University Health Network, Princess Margaret Cancer Center, Toronto, Canada ...
July 22, 2019 
ViewRay Inc. announced that the company's MRIdian System is the focus of more than 40 abstracts selected by the American Association of Physicists in Medicine (AAPM) for presentation during their 2019 Annual Meeting, July 14-18 in San Antonio, Texas.
July 16, 2019 
Revenues from the magnetic resonance imaging (MRI)-guided radiation therapy systems market exceeded $220 million in 2018, according to a recent study, suggesting increasing prevalence for the integrated technologies. According to the study from Fact.MR, the growth potential — projected at approximately a 20 percent compound annual growth rate (CAGR) through 2028 — can be attributed to burgeoning adoption of innovative technologies in cancer diagnosis and treatment, alongside growing focus on patient-centric care.
June 06, 2019 This is a walk through of the ViewRay MRIdian MRI-guided radiotherapy system installed at Henry Ford Medical Center — ...
May 21, 2019 
February 21, 2019 — ViewRay Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market ...
February 21, 2019 
A linear accelerator combined with high-field MRI could soon be on the U.S. market. If U.S. regulators do as expected ...
October 20, 2018 Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute, describes the benefits the department ...
October 15, 2018